Skip to main content
    E

    EyePoint, Inc (EYPT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.31
    +0.00 (+0.52%)

    Market Cap: $34.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    EyePoint, Inc (EYPT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to EyePoint are Hyperion DeFi (HYPD), OS Therapies (OSTX) and OKYO Pharma (OKYO). By market cap, EyePoint ranks 8th of the 13 companies on this page; OUTLOOK THERAPEUTICS INC (OTLK) is the largest at $100.54M.

    Peer Comparison

    EYPT's revenue growth of -21.7% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    EyePoint (EYPT)$34.82MN/A10.6x0.0%N/A-21.7%0.00%
    Hyperion DeFi, Inc. (HYPD)$39.84MN/A20.3x474.9%22.2%1560.0%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    OKYO Pharma Limited (OKYO)$70.85MN/AN/A0.0%N/A0.0%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    Pelthos Therapeutics Inc. (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    eXoZymes, Inc. (EXOZ)$35.64MN/AN/A0.0%-455.6%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Peer median$35.25MN/A2.2x0.0%-275.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to EyePoint, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Hyperion DeFi, Inc. (HYPD)
    Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
    HYPD competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    OKYO Pharma Limited (OKYO)
    OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye...
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    Pelthos Therapeutics Inc. (PTHS)
    Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
    PTHS competitors
    eXoZymes, Inc. (EXOZ)
    eXoZymes, Inc. is a synthetic biochemical company in the United States. The company is headquartered in Monrovia, California.
    EXOZ competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    OUTLOOK THERAPEUTICS INC (OTLK)
    Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic...
    OTLK competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.

    Frequently Asked Questions About EYPT

    Who are EyePoint's main competitors?

    The companies most similar to EyePoint include Hyperion DeFi (HYPD), OS Therapies (OSTX), OKYO Pharma (OKYO), Edesa Biotech (EDSA) and Pelthos Therapeutics (PTHS), listed from the closest match.

    Who is EyePoint's biggest competitor?

    OUTLOOK THERAPEUTICS INC (OTLK) is the largest of the similar companies at $100.54M; Hyperion DeFi (HYPD) is the closest match by business profile, size, sector and industry.

    How does EYPT stock compare with its competitors?

    EYPT's P/S is 10.6x against a peer median of 2.2x; its net margin is 0.0% against a peer median of 0.0%.

    Which of EyePoint's competitors pays a higher dividend?

    EyePoint pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is EyePoint bigger than its competitors?

    No. EyePoint is 8th by market cap among the 13 companies on this page; the largest is OUTLOOK THERAPEUTICS INC (OTLK) at $100.54M.